[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 2872 Introduced in Senate (IS)]
<DOC>
114th CONGRESS
2d Session
S. 2872
To require the Government Accountability Office to submit to Congress a
report on neonatal abstinence syndrome (NAS) in the United States and
its treatment under Medicaid.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
April 28, 2016
Mrs. Capito (for herself, Mr. Brown, and Mr. King) introduced the
following bill; which was read twice and referred to the Committee on
Finance
_______________________________________________________________________
A BILL
To require the Government Accountability Office to submit to Congress a
report on neonatal abstinence syndrome (NAS) in the United States and
its treatment under Medicaid.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Nurturing And Supporting Healthy
Babies Act'' or as the ``NAS Healthy Babies Act''.
SEC. 2. GAO REPORT ON NEONATAL ABSTINENCE SYNDROME (NAS).
(a) In General.--Not later than one year after the date of the
enactment of this Act, the Comptroller General of the United States
shall submit to the Committee on Energy and Commerce of the House of
Representatives and the Committee on Finance and the Committee on
Health, Education, Labor, and Pensions of the Senate a report on
neonatal abstinence syndrome (in this section referred to as ``NAS'')
in the United States.
(b) Information To Be Included in Report.--Such report shall
include information on the following:
(1) The prevalence of NAS in the United States, including
the proportion of children born in the United States with NAS
who are eligible for medical assistance under State Medicaid
programs under title XIX of the Social Security Act at birth
and the costs associated with NAS through such programs.
(2) The services for which coverage is available under
State Medicaid programs for treatment of infants with NAS.
(3) The settings (including inpatient, outpatient,
hospital-based, and other settings) for the treatment of
infants with NAS and the reimbursement methodologies and costs
associated with such treatment in such settings.
(4) The prevalence of utilization of various care settings
under State Medicaid programs for treatment of infants with NAS
and any Federal barriers to treating such infants under such
programs, particularly in nonhospital-based settings.
(c) Recommendations.--Such report also shall include such
recommendations as the Comptroller General determines appropriate for
improvements that will ensure access to treatment for infants with NAS
under State Medicaid programs.
<all>